Cosmo Pharmaceuticals N.V. financials at a glance

Year Year 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2006 2024
Rev. Revenue
CHF22.42M CHF34.21M CHF26.69M CHF32.05M CHF33.78M CHF59.60M CHF57.39M CHF79.64M CHF60.63M CHF68.39M CHF67.71M CHF65.62M CHF62.50M CHF60.95M CHF65.07M CHF102.09M CHF96.72M CHF16.25M CHF0.00M
GM % Gross Margin %
41.28% 61.40% 52.13% 55.30% 57.10% 72.83% 66.61% 72.95% 66.84% 70.98% 67.53% 66.38% 59.91% 54.69% 49.32% 60.34% 59.33% 62.68% 0.00%
OM Operating Margin
-1.11% 32.70% 16.65% 14.98% 26.37% 44.50% 22.54% 27.89% -8.96% 37.13% -14.18% -25.33% -19.69% 2.96% 17.06% 27.48% 12.64% -11.54% 0.00%
EPS Earnings Per Share
CHF-0.17 CHF0.68 CHF0.27 CHF0.24 CHF0.53 CHF1.40 CHF4.80 CHF2.02 CHF-0.24 CHF1.37 CHF-2.19 CHF-1.20 CHF-1.67 CHF-0.55 CHF1.31 CHF1.05 CHF0.07 CHF0.00
Div. Dividends
CHF0.00 CHF0.00 CHF0.00 CHF0.00 CHF0.00 CHF0.00 CHF1.00 CHF1.00 CHF1.40 CHF1.50 CHF1.50 CHF0.00 CHF0.00 CHF0.00 CHF0.00 CHF1.05 CHF2.00 CHF0.00 CHF0.00
PR % Payout Ratio %
-0.00% 0.00% 0.00% 0.00% 0 0 20.83% 49.50% -583.33% 109.49% -68.49% -0.00% -0.00% -0.00% 0.00% 100.00% 2857.14% 0 0
Sha. Shares
13.88m 13.88m 13.7m 14.85m 14.68m 13.65m 14.18m 14.25m 14.1m 14.1m 15.04m 15m 14.62m 14.46m 14.33m 16.38m 0m 0m 16.05m
OCF Operating Cash Flow
CHF-2.49M CHF12.52M CHF3.88M CHF7.79M CHF11.29M CHF23.00M CHF8.11M CHF66.45M CHF-39.26M CHF21.69M CHF-9.43M CHF-10.16M CHF-18.85M CHF12.99M CHF12.61M CHF33.23M CHF33.62M CHF5.72M CHF0.00M
FCF Free Cash Flow
CHF-3.44M CHF11.15M CHF2.65M CHF6.71M CHF10.18M CHF20.94M CHF6.16M CHF64.25M CHF-41.13M CHF7.98M CHF-22.30M CHF-12.06M CHF-21.09M CHF8.87M CHF7.12M CHF28.71M CHF45.55M CHF-1.20M CHF0.00M
FCFS Free Cash Flow Per Share
CHF-0.27 CHF0.51 CHF-0.21 CHF0.03 CHF0.55 CHF1.46 CHF0.39 CHF4.46 CHF-2.96 CHF0.23 CHF-2.12 CHF-1.32 CHF-2.47 CHF0.34 CHF0.25 CHF1.58 CHF1.14 CHF-0.46 CHF0.00